UniProt ID | CASP2_HUMAN | |
---|---|---|
UniProt AC | P42575 | |
Protein Name | Caspase-2 | |
Gene Name | CASP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 452 | |
Subcellular Localization | ||
Protein Description | Involved in the activation cascade of caspases responsible for apoptosis execution. Might function by either activating some proteins required for cell death or inactivating proteins necessary for cell survival.. | |
Protein Sequence | MAAPSAGSWSTFQHKELMAADRGRRILGVCGMHPHHQETLKKNRVVLAKQLLLSELLEHLLEKDIITLEMRELIQAKVGSFSQNVELLNLLPKRGPQAFDAFCEALRETKQGHLEDMLLTTLSGLQHVLPPLSCDYDLSLPFPVCESCPLYKKLRLSTDTVEHSLDNKDGPVCLQVKPCTPEFYQTHFQLAYRLQSRPRGLALVLSNVHFTGEKELEFRSGGDVDHSTLVTLFKLLGYDVHVLCDQTAQEMQEKLQNFAQLPAHRVTDSCIVALLSHGVEGAIYGVDGKLLQLQEVFQLFDNANCPSLQNKPKMFFIQACRGDETDRGVDQQDGKNHAGSPGCEESDAGKEKLPKMRLPTRSDMICGYACLKGTAAMRNTKRGSWYIEALAQVFSERACDMHVADMLVKVNALIKDREGYAPGTEFHRCKEMSEYCSTLCRHLYLFPGHPPT | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAPSAGSW ------CCCCCCCCC | 28.25 | 19413330 | |
5 | Phosphorylation | ---MAAPSAGSWSTF ---CCCCCCCCCCHH | 40.30 | 28122231 | |
8 | Phosphorylation | MAAPSAGSWSTFQHK CCCCCCCCCCHHHHH | 19.98 | 25159151 | |
10 | Phosphorylation | APSAGSWSTFQHKEL CCCCCCCCHHHHHHH | 22.50 | 28122231 | |
15 | Ubiquitination | SWSTFQHKELMAADR CCCHHHHHHHHHHHH | 41.58 | - | |
22 | Methylation | KELMAADRGRRILGV HHHHHHHHCCHHHHH | 35.47 | - | |
41 | Ubiquitination | PHHQETLKKNRVVLA HHHHHHHHHCHHHHH | 56.26 | - | |
42 | Ubiquitination | HHQETLKKNRVVLAK HHHHHHHHCHHHHHH | 53.77 | - | |
46 (in isoform 2) | Ubiquitination | - | 3.77 | 21906983 | |
62 (in isoform 2) | Ubiquitination | - | 55.85 | 21906983 | |
67 | Phosphorylation | LLEKDIITLEMRELI HHHCCCCCHHHHHHH | 19.59 | 20068231 | |
77 | Sumoylation | MRELIQAKVGSFSQN HHHHHHHHHCCCHHC | 30.65 | - | |
77 | Ubiquitination | MRELIQAKVGSFSQN HHHHHHHHHCCCHHC | 30.65 | 21906983 | |
77 (in isoform 1) | Ubiquitination | - | 30.65 | 21906983 | |
77 | Sumoylation | MRELIQAKVGSFSQN HHHHHHHHHCCCHHC | 30.65 | - | |
93 (in isoform 1) | Ubiquitination | - | 70.70 | 21906983 | |
93 | Ubiquitination | ELLNLLPKRGPQAFD HHHHCCCCCCHHHHH | 70.70 | 21906983 | |
107 | Methylation | DAFCEALRETKQGHL HHHHHHHHHHHCCHH | 57.49 | - | |
139 | Phosphorylation | LSCDYDLSLPFPVCE CCCCCCCCCCCCCCC | 30.97 | 22817900 | |
151 | Phosphorylation | VCESCPLYKKLRLST CCCCCCCHHHHCCCC | 7.39 | - | |
153 | Ubiquitination | ESCPLYKKLRLSTDT CCCCCHHHHCCCCCC | 25.86 | - | |
157 | Phosphorylation | LYKKLRLSTDTVEHS CHHHHCCCCCCCCHH | 20.15 | 23401153 | |
158 | Phosphorylation | YKKLRLSTDTVEHSL HHHHCCCCCCCCHHC | 40.04 | 22617229 | |
160 | Phosphorylation | KLRLSTDTVEHSLDN HHCCCCCCCCHHCCC | 28.07 | 28102081 | |
164 | Phosphorylation | STDTVEHSLDNKDGP CCCCCCHHCCCCCCC | 24.74 | 28450419 | |
168 | Ubiquitination | VEHSLDNKDGPVCLQ CCHHCCCCCCCEEEE | 64.82 | - | |
177 | Ubiquitination | GPVCLQVKPCTPEFY CCEEEEEECCCHHHH | 22.78 | - | |
214 | Ubiquitination | NVHFTGEKELEFRSG CCEECCCEEEEECCC | 69.78 | - | |
254 | Ubiquitination | TAQEMQEKLQNFAQL HHHHHHHHHHHHHHC | 38.18 | - | |
284 | Phosphorylation | HGVEGAIYGVDGKLL CCCCCEEECCCCCCH | 15.57 | 29496907 | |
311 | Ubiquitination | NCPSLQNKPKMFFIQ CCHHHCCCCCEEEEE | 32.81 | - | |
335 | Ubiquitination | GVDQQDGKNHAGSPG CCCCCCCCCCCCCCC | 54.58 | - | |
340 | Phosphorylation | DGKNHAGSPGCEESD CCCCCCCCCCCCCCH | 20.92 | 23401153 | |
346 | Phosphorylation | GSPGCEESDAGKEKL CCCCCCCCHHCCCCC | 15.51 | 29396449 | |
350 | Ubiquitination | CEESDAGKEKLPKMR CCCCHHCCCCCCCCC | 54.09 | - | |
352 | Ubiquitination | ESDAGKEKLPKMRLP CCHHCCCCCCCCCCC | 73.84 | - | |
368 | Phosphorylation | RSDMICGYACLKGTA CCCCCHHHHHHHCCH | 6.96 | - | |
374 | Phosphorylation | GYACLKGTAAMRNTK HHHHHHCCHHHCCCC | 15.06 | - | |
384 | Phosphorylation | MRNTKRGSWYIEALA HCCCCCCCHHHHHHH | 22.27 | 24144214 | |
395 | Phosphorylation | EALAQVFSERACDMH HHHHHHHHHHCCHHH | 27.58 | 24144214 | |
409 | Ubiquitination | HVADMLVKVNALIKD HHHHHHHHHHHHHCC | 26.30 | - | |
415 | Ubiquitination | VKVNALIKDREGYAP HHHHHHHCCCCCCCC | 52.13 | 2190698 | |
415 (in isoform 1) | Ubiquitination | - | 52.13 | 21906983 | |
420 | Phosphorylation | LIKDREGYAPGTEFH HHCCCCCCCCCCCCH | 12.60 | - | |
430 | Ubiquitination | GTEFHRCKEMSEYCS CCCCHHHHHHHHHHH | 57.31 | - |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CASP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CASP2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CRADD_HUMAN | CRADD | physical | 15073321 | |
PIDD1_HUMAN | PIDD1 | physical | 15073321 | |
CRADD_HUMAN | CRADD | physical | 11156409 | |
BID_HUMAN | BID | physical | 11399776 | |
CASP2_HUMAN | CASP2 | physical | 11832478 | |
BID_HUMAN | BID | physical | 11832478 | |
BCL2_HUMAN | BCL2 | genetic | 11832478 | |
B2CL1_HUMAN | BCL2L1 | genetic | 11832478 | |
CASP9_HUMAN | CASP9 | genetic | 11832478 | |
XIAP_HUMAN | XIAP | genetic | 11832478 | |
NOL3_HUMAN | NOL3 | physical | 9560245 | |
CCND3_HUMAN | CCND3 | physical | 12011445 | |
MDM2_HUMAN | MDM2 | physical | 21726810 | |
RAI1_HUMAN | RAI1 | physical | 21900206 | |
EF1A1_HUMAN | EEF1A1 | physical | 21900206 | |
RXRA_HUMAN | RXRA | physical | 21900206 | |
RL30_HUMAN | RPL30 | physical | 21988832 | |
CRADD_HUMAN | CRADD | physical | 23049853 | |
CRYAB_HUMAN | CRYAB | physical | 23049853 | |
CASP2_HUMAN | CASP2 | physical | 25416956 | |
CRADD_HUMAN | CRADD | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. |